🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well radium-223 dichloride and paclitaxel w...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2020-08-04
Trial ID
NCT04090398
This phase Ib trial tests the safety and tolerability of ZEN003694 in combi...
Status
Recruiting
Location
Boston Medical Center
Start Date
2023-05-18
Trial ID
NCT05422794
This phase II trial tests how well giving CIMAvax-EGF with KRAS G12C inhibi...
Status
Not Yet Recruiting
Location
Roswell Park Cancer Institute
Start Date
2026-09-01
Trial ID
NCT07543172
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2008-01-25
Trial ID
NCT00610493
Treatments Being Tested
A phase II, single-center, non-profit, interventional study on patients aff...
Status
Recruiting
Location
Department of Surgical Oncology - FPO-IRCCS Institute for Cancer Research and Treatment
Start Date
2024-04-30
Trial ID
NCT06952101
Treatments Being Tested
This phase II trial tests how well CPI-613 (devimistat) in combination with...
Status
Recruiting
Location
Northwestern University
Start Date
2023-03-08
Trial ID
NCT05733000
This phase I trial tests the safety, best dose, and effectiveness of NXP800...
Status
Terminated
Location
Mayo Clinic in Arizona
Start Date
2024-05-31
Trial ID
NCT06420349
This is a prospective imaging study evaluating the utility of baseline meta...
Status
Suspended
Location
University of California, San Francisco
Start Date
2020-07-16
Trial ID
NCT04346225
Treatments Being Tested
This phase II trial tests how well personalized reduction of chemotherapy (...
Status
Recruiting
Location
City of Hope
Start Date
2025-03-06
Trial ID
NCT06745076
This phase II trial studies how well atezolizumab when given with glycosyla...
Status
Completed
Location
Kaiser Permanente-Riverside
Start Date
2019-06-05
Trial ID
NCT03513952